Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

2021/12/23 by Delphine Planas, Nell Saunders, Piet Maes +36 · 6 citations
Medicine · #COVID-19 Clinical Research Studies #SARS-CoV-2 and COVID-19 Research #SARS-CoV-2 detection and testing

paper · pdf · doi:10.1038/s41586-021-04389-z

crossref issued 2021/12/23 · crossref published 2021/12/23 · crossref published-online 2021/12/23 · openalex publication_date 2021/12/23 · crossref created 2022/01/11 · crossref deposited 2022/02/23 · crossref published-print 2022/02/24 · openalex created_date 2025/10/10 · crossref indexed 2026/08/01 · openalex updated_date 2026/08/04

Citations

• Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
• Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
• Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
• Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Cited by

• Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
• BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
• Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
• Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
• Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
• SARS-CoV-2 Omicron variant [wikipedia]